These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 16291415

  • 1. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.
    Donofrio PD, Raskin P, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI, CAPSS-141 Study Group.
    Clin Ther; 2005 Sep; 27(9):1420-31. PubMed ID: 16291415
    [Abstract] [Full Text] [Related]

  • 2. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J.
    Headache; 2006 Sep; 46(7):1151-60. PubMed ID: 16866719
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 4. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 5. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects.
    Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI, CAPSS-141 Study Group.
    Neurology; 2004 Sep 14; 63(5):865-73. PubMed ID: 15365138
    [Abstract] [Full Text] [Related]

  • 6. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar 14; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD, Hulihan J, Karim MR, Wu SC, Jordan D, Karvois D, Kamin M.
    Clin Ther; 2006 Jul 14; 28(7):1002-11. PubMed ID: 16990078
    [Abstract] [Full Text] [Related]

  • 8. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr 14; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 9. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials.
    Thienel U, Neto W, Schwabe SK, Vijapurkar U, Topiramate Diabetic Neuropathic Pain Study Group.
    Acta Neurol Scand; 2004 Oct 14; 110(4):221-31. PubMed ID: 15355485
    [Abstract] [Full Text] [Related]

  • 10. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep 14; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 11. Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy.
    Freeman R, Raskin P, Hewitt DJ, Vorsanger GJ, Jordan DM, Xiang J, Rosenthal NR, CAPSS-237 Study Group.
    Curr Med Res Opin; 2007 Jan 14; 23(1):147-61. PubMed ID: 17257476
    [Abstract] [Full Text] [Related]

  • 12. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
    Thisted RA, Klaff L, Schwartz SL, Wymer JP, Culligan NW, Gerard G, Pope LE, Berg JE.
    Clin Ther; 2006 Oct 14; 28(10):1607-18. PubMed ID: 17157116
    [Abstract] [Full Text] [Related]

  • 13. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
    Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M, OBES-002 Study Group.
    Int J Obes Relat Metab Disord; 2004 Nov 14; 28(11):1399-410. PubMed ID: 15486569
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S, Etropolski M, Shapiro DY, Okamoto A, Lange R, Haeussler J, Rauschkolb C.
    Curr Med Res Opin; 2011 Jan 14; 27(1):151-62. PubMed ID: 21162697
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y, Ding X, Cheng Y, Fan D, Tan L, Wang Y, Zhao Z, Hong Z, Zhou D, Pan X, Chen S, Martin A, Tang H, Cui L.
    Clin Ther; 2011 Feb 14; 33(2):159-66. PubMed ID: 21444113
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 14; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 17. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.
    Connor GS, Edwards K, Tarsy D.
    Clin Neuropharmacol; 2008 Jun 14; 31(2):97-103. PubMed ID: 18382182
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 14; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 19. Time course of adverse events most commonly associated with topiramate for migraine prevention.
    Láinez MJ, Freitag FG, Pfeil J, Ascher S, Olson WH, Schwalen S.
    Eur J Neurol; 2007 Aug 14; 14(8):900-6. PubMed ID: 17662012
    [Abstract] [Full Text] [Related]

  • 20. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J, Topiramate Pediatric Migraine Study Investigators.
    Headache; 2005 Aug 14; 45(10):1304-12. PubMed ID: 16324162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.